# FeelBetter

> FeelBetter is a Boston and Tel Aviv healthcare software company that helps clinical teams find patients whose combined medicines may be causing harm or missing the mark. Its AI platform ranks medication-related risk, proposes patient-specific changes, routes cases to pharmacists and clinicians, and tracks what happens next. It serves health systems, accountable care organizations, insurers and long-term care providers; the company says its platform has served more than 400,000 patients.

- **Founded:** 2018
- **Headquarters:** Boston, United States; Tel Aviv, Israel
- **Founders:** Liat Primor (Co-founder and CEO), Yoram Hordan (Co-founder and COO/CTO)
- **Products:** Precision Population Health platform, MedBuddy
- **Notable:** A 2024 peer-reviewed retrospective cohort study examined 108,817 older patients and found the highest risk percentile had 17.3 times the odds of hospitalization versus the middle reference group over three months., In the same study, pharmacists judged 1,151 of 1,290 reviewed high-priority warnings correct (89.2%); the study did not test whether acting on them improved outcomes., Leumit reported a 24% reduction in preventable hospitalizations among high-risk polypharmacy patients and 350% more clinical interventions in a 12-month deployment involving more than 170,000 patients; these are partner-reported results.

## Products & services

- **Precision Population Health platform** — AI-supported medication risk stratification, regimen recommendations, clinical workflow management and post-intervention monitoring; marketed through Insight, Navigator, Action and Impact modules.
- **MedBuddy** — AI pharmacotherapy assistant advertised for patient insights, recommended interventions and automated clinical actions; the company advertised beta early access for Q1 2026.

## Achievements

- A 2024 peer-reviewed retrospective cohort study examined 108,817 older patients and found the highest risk percentile had 17.3 times the odds of hospitalization versus the middle reference group over three months.
- In the same study, pharmacists judged 1,151 of 1,290 reviewed high-priority warnings correct (89.2%); the study did not test whether acting on them improved outcomes.
- Leumit reported a 24% reduction in preventable hospitalizations among high-risk polypharmacy patients and 350% more clinical interventions in a 12-month deployment involving more than 170,000 patients; these are partner-reported results.
- FeelBetter says its platform has served more than 400,000 patients.

## Latest updates

- **2026-01** — MedBuddy page advertised beta early access for Q1 2026; a general release was not confirmed on that page.
- **2025-09** — Chief Medical Officer Adva Tzuk Onn published an essay on personalized, data-driven medication management.
- **2024-11** — Americare partnership announced, with PointClickCare integration after an eight-facility pilot.
- **2024-08** — Peer-reviewed FeelBetter evaluation published in The American Journal of Managed Care.

## Links

- Website: https://www.feelbetter.healthcare/
- LinkedIn: https://www.linkedin.com/company/feelbetter-ltd

---

Profile page: https://yespress.io/feelbetter
Published by YesPress — https://yespress.io
Last updated: 2026-09-29